Trials / Completed
CompletedNCT00033215
A Phase 1 Study of S-3304 in Patients With Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Shionogi · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
To determine the maximum tolerated dose and safety profile of S-3304 in patients with biopsy accessible cancer who have failed previous therapy or to whom no standard therapies are available. To determine the pharmacokinetic profile of S-3304 in this patient population
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | S-3304 |
Timeline
- Start date
- 2001-11-01
- Primary completion
- 2003-02-13
- Completion
- 2003-03-12
- First posted
- 2002-04-10
- Last updated
- 2018-04-26
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT00033215. Inclusion in this directory is not an endorsement.